Select Page

The M-POWER project is partnering with cities across the country to turn the core vision of the IMF Diversity Initiative into a reality: improving the short- and long-term outcomes of African-American patients with multiple myeloma.

Multiple myeloma is the most common blood cancer in African Americans, who have a greater-than-average risk of developing the disease. But when barriers to early diagnosis and treatment are removed, African-American myeloma patients do just as well, or even better than, white individuals.

M-POWER is empowering health-care professionals, community leaders, neighborhoods and families to break down those barriers by raising myeloma awareness. Get M-POWERed to change the course of myeloma by clicking on a city below.

We invite you to visit one of our M-POWERed cities

Abstracts on racial disparities in myeloma care

IMF Chief Medical Officer Dr. Joseph Mikhael (TGen, City of Hope — Phoenix) talks about abstracts on racial disparities in myeloma care as reported from this year’s American Society of Hematology (ASH) annual conference held in Atlanta, GA. 

We want to hear from you: